Skip to content
Use caution Drug recall · FDA · Published May 7, 2012

Endocet Recall: Foreign Tablets in Endocet Bottles

Endo Pharmaceuticals recalls Endocet 10 mg/650 mg tablets due to adulteration with foreign tablets. Check your lot number and expiration date.

🇺🇸 FDA recall #D-1381-2012DrugEndo Pharmaceuticals ›
Take action

Contact the company

Recalling firmEndo Pharmaceuticals, Inc.100 Endo Blvd · Chadds Ford, PA 19317
✎ GovInfoNow plain-language explainer

Endo Pharmaceuticals is recalling specific bottles of Endocet (oxycodone and acetaminophen) tablets, USP, 10 mg/650 mg because some were found mixed with Endocet 10 mg/325 mg tablets. This recall affects 11,764 bottles distributed nationwide and in Puerto Rico. The record does not specify a remedy or action for consumers. Read more at govinfonow.com/recall/48895-endo-pharmaceuticals-inc-recalls-endocet-oxycodone-and-acetaminophen-tablets-usp.

Source Summary by GovInfoNow · govinfonow.com/recall/48895-endo-pharmaceuticals-inc-recalls-endocet-oxycodone-and-acetaminophen-tablets-usp · Updated October 13, 2026 · FDA enforcement record: FDA #D-1381-2012

Cite this page

“Endocet Recall: Foreign Tablets in Endocet Bottles.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/48895-endo-pharmaceuticals-inc-recalls-endocet-oxycodone-and-acetaminophen-tablets-usp. Based on FDA recall #D-1381-2012 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1381-2012%22&limit=1).

The FDA announced on May 7, 2012, that Endo Pharmaceuticals, Inc. voluntarily recalled Endocet (oxycodone and acetaminophen) tablets due to the adulterated presence of foreign tablets. The agency stated that some Endocet 10 mg/325 mg tablets were found mixed in bottles with the intended 10 mg/650 mg dosage.

How to tell if you have it

  • Brand: Endo Pharmaceuticals
  • Product: Endocet 10 mg/650 mg Tablets
  • NDC: 60951-797-70
  • Lot #: 402794NV
  • Expiration Date: 12/13
  • Quantity: 11,764 bottles

The hazard

The hazard involves the adulterated presence of foreign tablets, specifically Endocet 10 mg/325 mg tablets mixed in with bottles containing Endocet 10 mg/650 mg tablets. This issue was identified following a customer complaint.

Context

GovInfoNow's records show Endo Pharmaceuticals, Inc. has had four other recalls on record since February 22, 2017. Other recent recalls of similar products include Endo Clonazepam Tablets Recalled Due to Labeling Error (July 10, 2024), Endo Recalls Calcitonin Salmon Nasal Spray Due to Impurity Issues (March 2, 2023), and Endo Robaxin 750mg Tablets: Incorrect Dosage Label Recall (September 17, 2018). Other recent recalls of similar products include Annora Pharma Pitavastatin Tablets 2mg Recall (February 3, 2026), Taro Recalls Children's Ibuprofen Due to Foreign Substance (March 2, 2026), and Endo USA Buprenorphine Injection Recall (March 13, 2026).

How to tell if you have this one

Check if you have Endocet (oxycodone and acetaminophen) tablets, USP, 10 mg/650 mg, in a 100-count bottle. Look for NDC 60951-797-70, Lot #402794NV, and an expiration date of 12/13.

  • Brand
    Endo Pharmaceuticals
  • Category
    Drug

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 13 months after the firm started it.

1. Firm started the recall: May 7, 201212. FDA classified it Class III: Jun 14, 201223. Published in FDA’s Enforcement Report: Jun 20, 201234. FDA terminated the recall: Jun 21, 2013420122013
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1381-2012 (May 7, 2012) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1381-2012 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA